SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A strong third-quarter report and raised revenue outlook, driven by demand for Mounjaro and Zepbound, are fueling Lillys breakout and a wave of analyst upgrades. Traders are also weighing the growth outlook against a lower profit forecast tied to acquisition-related R&D charges, weaker-than-expected Foundayo sales and concerns about valuation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders weigh Middle East supply risksespecially reported attacks and threats around the Strait of Hormuzagainst possible US-Iran negotiations that could ease oil prices. Bulls cite disrupted flows and escalation risks, while bears argue that a deal or de-escalation could quickly unwind the geopolitical premium.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake is drawing attention as traders await the FDAs decision on whether to accept its sonelokimab application for hidradenitis suppurativa and what review timeline it will receive. The community is split between optimism about the drug and upcoming regulatory milestone and concern over approval risk, commercialization plans, and continued weakness in biotech shares.

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Clorox Co.

Cloroxs steep decline has fueled debate over its turnaround, with investors split between buying the beaten-down dividend stock and worrying about weak sales, execution and dividend sustainability. Upcoming quarterly results and the incoming CEOs ability to revive growth are also in focus.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention ahead of its quarterly report, with traders weighing whether guidance can hold against concerns about its Caremark PBM business and Aetnas Medicare Advantage outlook. Some see an undervalued, defensive healthcare business, while others remain wary of the operating and reimbursement pressures.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.

Wells Fargo & Co.

Wells Fargos Q3 results are driving attention: earnings topped expectations, but a revenue and net interest income shortfall, alongside higher loan-loss provisions, weighed on shares. Traders are split between concern over lending trends and the view that profit growth and healthy business activity remain supportive.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Schwab and thinkorswim platform outages are drawing attention, with many users reporting login problems, inaccurate quotes, and inability to place or manage trades. Frustration is widespread, and some traders say the recurring reliability issues are prompting them to consider moving to other brokerages.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is falling with semiconductor and technology stocks as Intels weak outlook and broader doubts about AI infrastructure spending and returns pressure the sector ahead of AMDs earnings. Traders debate whether the move is sympathy sellingwith some arguing Intels struggles could benefit AMDor a warning about stretched valuations and cooling AI expectations.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs October deliveries rose month over month, prompting debate over whether the growth can support its ambitious fourth-quarter delivery pace. Bulls see the delivery trend as evidence of demand, while skeptics remain focused on uncertainty around guidance and the stocks prolonged decline.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Discussion is dominated by GameStop warrants reportedly expiring worthless, with traders split over whether that removes a dilution overhang or leaves warrant holders with losses and reflects poorly on management. Speculation about Roaring Kittys changed X profile and a possible return is adding excitement, but no return is confirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXCLUSIVE: Scienture Revenue Soars 256% As Drugmaker Targets 2027 Profitability

Scienture Holdings reports Q3 revenue of $1.22M, up 256% QoQ, driven by Arbli growth and the launch of Rezenopy.read more...

Children's Hospital Formulary Wins Lift Liquid Blood Pressure Drug Maker

For children who cannot swallow tablets or need individualized doses, the pharmacy often becomes the final step in manufacturing their medicine. Ready-to-use liquid formulations can remove that preparation burden, but hospital formulary access is an important step toward getting them into routine care.Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are climbing Friday after the company announced that Arbli&#8482;, its losartan potassium oral suspension, has been added to the formularies of three leading U.S. pediatric academic medical centers and hospitals. The institutions specialize in ...

SCIENTURE Scores Major Pediatric Breakthrough as Arbli Lands at 3 Top U.S. Hospitals

SCIENTURE (NASDAQ:SCNX) is giving investors a fresh commercial catalyst as its FDA-approved Arbli oral suspension wins formulary placement at three leading U.S. pediatric academic medical centers and hospitals. The additions expand the product’s institutional footprint at a critical point in its rollout, while the company says wholesale orders have continued to increase sequentially. For a specialty pharmaceutical company focused on products addressing specific patient and healthcare-system needs, the latest formulary wins provide a tangible measure of expanding access for Arbli.

Scienture Holdings (SCNX) Stock Drops 19% After Hours: Here's What Happened

Scienture Holdings shares tumble 19% after hours following a newly announced 1-for-25 reverse stock split.read more...

Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why

Scienture Holdings shares jumped 23.54% overnight after the company completed manufacturing inventory for the commercial launch of REZENOPY.read more...

Scienture Holdings Stock Climbs 31% After GPO Agreements For REZENOPY Naloxone Spray

(RTTNews) - Shares of Scienture Holdings, Inc. (SCNX) are moving up about 31 percent on Wednesday morning trading after the company formalized multiple commercial Group Purchasing Organization...

Why Is Scienture Stock Rising Today?

Equity

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Commack, NY.

Scienture Holdings Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation.</li><li>The U.S. losartan market is worth about $256 million annually, offering strong growth potential for Arbli.</li><li>Scienture secured key GPO agreements to expand Arbli’s availability to over 2,500 healthcare facilities nationwide.</li></ul>Scienture Holdings Inc. (SCNX) on Thursday announced the launch of commercial sales for its new product, Arbli (losartan potassium) Oral Suspension, 10 mg/mL.Arbli is the first FDA-approved, ready-to-use oral suspension of losartan potassium, offering patients who require alternatives to pills a safe and consistent treatment option.&nbsp;With the U.S. losartan market generating around $256 million annually and more than 71 million prescriptions written each year, according to IQVIA data, Scienture sees a strong potential for this new product.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Shares of Scienture Holdings surged by more than 122% by Thursday noon. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:938/107;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_23_114143_png_e27a7261e9.webp" alt="SCNX’s Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits" width="938" height="107"><figcaption>SCNX’s Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user said the company’s valuation might reach billions if the product is expanded globally.&nbsp;<stembedurl>https://stocktwits.com/jreddyN/message/633437362</stembedurl><h2 class="st-heading-2">Arbli’s Importance</h2>Arbli is a unique liquid form of losartan, a common medication for high blood pressure. It doesn’t need compounding, offers a smaller dosing volume, and has a long shelf life at room temperature. Arbli is approved to treat hypertension in patients over six years old, to lower stroke risk in those with hypertension and heart enlargement, and manage diabetic kidney disease in certain type 2 diabetes patients.To support Arbli’s market entry, Scienture has secured Pharmacy Benefit Manager-led Group Purchasing Organization (PBM-Led GPO) agreements to broaden commercial coverage and formulary inclusion. Scienture has also finalized contracts with multiple commercial GPOs, allowing Arbli to reach over 2,500 healthcare institutions nationwide.&nbsp;Scienture’s stock has lost over 79% in 2025 and over 82% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/datavault-ai-to-boost-growth-with-new-headquarters-quantum-centers/cLG4mQdR3rQ">Datavault AI To Boost Growth With New Headquarters, Quantum Centers</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.22
Prev Close	$3.49
Open	$3.42
Dividend Yield	0.00%
50-Day Moving Average	$6.33
Beta	1.55
Avg. Volume	60,864.96
PE Ratio	-0.07

52-Week High	$27.75
52-Week Low	$2.64
Market Capitalization	$5.29M
EPS (Annual)	-$67.62
Price to Book	0.08
Revenue Per Employee	$47,956.56

Feed

News

Sentiment

Fundamentals

Info

SCNX Fundamentals